Deadline: December 04, 2025
The European Union has launched a call under the EU4Health Programme (EU4H-2025-HERA-PJ-1-a) to support the development of innovative medical countermeasures for chemical, biological, radiological and nuclear threats with a focus on medicinal products.
This action will focus on supporting advanced research on threat-agnostic medical countermeasures against CBRN agents and platform approaches to treat injuries from CBRN agents. The objective is to improve the Union’s readiness to respond to intentional health threats, including cross-border ones, by supporting the development of medical countermeasures to biological, chemical and radio-nuclear agents for which there currently are no or only limited treatment options. The focus of sub-topic a) is on medicinal products, i.e. vaccines and therapeutics against biological, chemical and radio-nuclear threats.
The call supports activities that bridge the gap between research, innovation, and deployment. It includes advanced research and development to support the development of medical countermeasures, involvement of end users and security practitioners to bring products closer to market readiness, and support for market readiness research or entrepreneurial skills development. Projects are expected to progress one or more countermeasures along the steps toward regulatory approval and market readiness.
The expected impact is to strengthen the Union’s preparedness to respond to CBRN threats by advancing vaccines, therapeutics such as antivirals, small molecules, antimicrobials, monoclonals and polyclonals for biological threats, antidotes and supportive treatments for chemical agents, as well as treatments against acute radiation syndrome, bone marrow suppression, and decorporation agents for radio-nuclear exposure.
The call targets a wide range of applicants, including secondary or higher education establishments, research organisations, hospitals, expert networks, security practitioners, end users, private entities, public bodies, and public authorities. The available budget for this sub-topic is EUR 18,000,000, with an expected 2–3 grant agreements to be signed, and projects should range between 24 and 48 months with budgets between EUR 5,500,000 and EUR 9,000,000.
For more information, visit EC.
